Schlossmacher MG - Search Results

1

Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition.

Bandopadhyay R, Kingsbury AE, Muqit MM, Harvey K, Reid AR, Kilford L, Engelender S, Schlossmacher MG, Wood NW, Latchman DS, Harvey RJ, Lees AJ. Bandopadhyay R, et al. Among authors: schlossmacher mg. Neurobiol Dis. 2005 Nov;20(2):401-11. doi: 10.1016/j.nbd.2005.03.021. Neurobiol Dis. 2005. PMID: 15894486

2

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.

Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ. Shimura H, et al. Among authors: schlossmacher mg. Science. 2001 Jul 13;293(5528):263-9. doi: 10.1126/science.1060627. Epub 2001 Jun 28. Science. 2001. PMID: 11431533

3

Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.

Schlossmacher MG, Frosch MP, Gai WP, Medina M, Sharma N, Forno L, Ochiishi T, Shimura H, Sharon R, Hattori N, Langston JW, Mizuno Y, Hyman BT, Selkoe DJ, Kosik KS. Schlossmacher MG, et al. Am J Pathol. 2002 May;160(5):1655-67. doi: 10.1016/S0002-9440(10)61113-3. Am J Pathol. 2002. PMID: 12000718 Free PMC article.

4

Parkinson's disease: assays for the ubiquitin ligase activity of neural Parkin.

Schlossmacher MG, Shimura H. Schlossmacher MG, et al. Methods Mol Biol. 2005;301:351-69. doi: 10.1385/1-59259-895-1:351. Methods Mol Biol. 2005. PMID: 15917645

5

Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers.

Pramstaller PP, Schlossmacher MG, Jacques TS, Scaravilli F, Eskelson C, Pepivani I, Hedrich K, Adel S, Gonzales-McNeal M, Hilker R, Kramer PL, Klein C. Pramstaller PP, et al. Among authors: schlossmacher mg. Ann Neurol. 2005 Sep;58(3):411-22. doi: 10.1002/ana.20587. Ann Neurol. 2005. PMID: 16130111

6

The effects of oxidative stress on parkin and other E3 ligases.

LaVoie MJ, Cortese GP, Ostaszewski BL, Schlossmacher MG. LaVoie MJ, et al. Among authors: schlossmacher mg. J Neurochem. 2007 Dec;103(6):2354-68. doi: 10.1111/j.1471-4159.2007.04911.x. Epub 2007 Sep 19. J Neurochem. 2007. PMID: 17883392 Free article.

7

Dopamine covalently modifies and functionally inactivates parkin.

LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ. LaVoie MJ, et al. Among authors: schlossmacher mg. Nat Med. 2005 Nov;11(11):1214-21. doi: 10.1038/nm1314. Epub 2005 Oct 16. Nat Med. 2005. PMID: 16227987

8

RING finger 1 mutations in Parkin produce altered localization of the protein.

Cookson MR, Lockhart PJ, McLendon C, O'Farrell C, Schlossmacher M, Farrer MJ. Cookson MR, et al. Hum Mol Genet. 2003 Nov 15;12(22):2957-65. doi: 10.1093/hmg/ddg328. Epub 2003 Sep 30. Hum Mol Genet. 2003. PMID: 14519684

9

Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative.

Laurens B, Constantinescu R, Freeman R, Gerhard A, Jellinger K, Jeromin A, Krismer F, Mollenhauer B, Schlossmacher MG, Shaw LM, Verbeek MM, Wenning GK, Winge K, Zhang J, Meissner WG. Laurens B, et al. Among authors: schlossmacher mg. Neurobiol Dis. 2015 Aug;80:29-41. doi: 10.1016/j.nbd.2015.05.004. Epub 2015 May 15. Neurobiol Dis. 2015. PMID: 25982836 Review.

10

Amyloid beta-peptide is produced by cultured cells during normal metabolism.

Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, et al. Haass C, et al. Among authors: schlossmacher mg. Nature. 1992 Sep 24;359(6393):322-5. doi: 10.1038/359322a0. Nature. 1992. PMID: 1383826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page